Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism (VTE) in Korea and Taiwan
Phase of Trial: Phase IV
Latest Information Update: 18 Aug 2017
At a glance
- Drugs Edoxaban (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms ETNA-VTE-KOR-TWN
- Sponsors Daiichi Sankyo Inc
- 04 Aug 2017 Status changed from not yet recruiting to recruiting.
- 13 Apr 2017 Planned initiation date changed from 1 Mar 2017 to 1 Apr 2017.
- 09 Nov 2016 New trial record